https://m2.mtmt.hu/hun2026-04-30 09:43JournalArticle31233247VALIDATEDtrueNicolae Testemitanu, State University of Medicine and Pharmacy, Chisinau, Israel
Department of Cardiology, Medical Centre Hungarian Defence Forces, Budapest, Hungary
Department of Internal Medicine 2, Azerbaijan Medical University, Baku, Azerbaijan
Cardiology Department, Mitera General Clinic - Hygeia Group, Athens, Greece
Hygeia Hospitals Group, Heart Sector, Athens, Greece
Cited By :35
Export Date: 7 January 2025
CODEN: EJHFF
Correspondence Address: Vardas, P.; Hygeia Hospitals Group, Greece; email: pvardas@hygeia.gr
Chemicals/CAS: adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5
Funding text 1: P.V. declares modest educational grants from Menarini International and consultation fees from the European Society of Cardiology, Dean Medicus, Servier, WeHealth and Menarini Greece. The other authors have nothing to disclose. Conflict of interest:0false2026-04-17T10:11:03.199+00002022-12-16T10:00:14.913+00002020-03-09T19:11:26.594+0000true10026589TichyRita
/api/admin/10026589
Admintrue100265892025-09-19T08:30:29.438+00002025-09-19T08:30:29.438+00002021-02-12T19:35:51.831+0000true10026589TichyRita
/api/admin/10026589
Admintrue10026589truefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue1134514Survey papertrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/1134514
Összefoglaló cikkSubType102true1134514true1
/api/category/1
Categorytrue1Cabac-Pogorevici, I.Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technologytruetrue
/api/journal/22711
REVIEWEDtruefalse22711false22711true1388-98421879-0844JournalFOREIGN2257897997891120202020truetruetruefalsefalsefalseNONE2026-04-17false530535205352532853535252521053525352066FolyóiratcikkJournal Article2453KönyvrészletChapter in Book250KönyvBook230Egyéb konferenciaközleményConference paper310Egyéb konferenciakötetConference proceedings320Oltalmi formákProtection forms260DisszertációThesis280EgyébMiscellaneous290AlkotásAchievement220Kutatási adatResearch data330FolyóiratcikkJournal Article24000KönyvrészletChapter in Book25000KönyvBook23000Egyéb konferenciaközleményConference paper31000Egyéb konferenciakötetConference proceedings32000Oltalmi formákProtection forms26000DisszertációThesis28000EgyébMiscellaneous29000AlkotásAchievement22000Kutatási adatResearch data3300020210666620220666620230666620240151415142025020202020D1Mosterd, A., Hoes, A.W., Clinical epidemiology of heart failure (2007) Heart, 93, pp. 1137-1146 ;
Briceno, N., Schuster, A., Lumley, M., Perera, D., Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation (2016) Heart, 102, pp. 397-406 ;
Felker, G.M., Shaw, L.K., O'Connor, C.M., A standardized definition of ischemic cardiomyopathy for use in clinical research (2002) J Am Coll Cardiol, 39, pp. 210-218 ;
Rahimtoola, S.H., The hibernating myocardium (1989) Am Heart J, 117, pp. 211-221 ;
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., Falk, V., van der Meer, P., 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC (2016) Eur J Heart Fail, 18, pp. 891-975 ;
Ong, S.B., Hernandez-Resendiz, S., Crespo-Avilan, G.E., Mukhametshina, R.T., Kwek, X.Y., Cabrera-Fuentes, H.A., Hausenloy, D.J., Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities (2018) Pharmacol Ther, 186, pp. 73-87 ;
Hofmann, U., Frantz, S., Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction (2015) Circ Res, 116, pp. 354-367 ;
Bansal, S.S., Ismahil, M.A., Goel, M., Zhou, G., Rokosh, G., Hamid, T., Prabhu, S.D., Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy (2019) Circulation, 139, pp. 206-221 ;
Crea, F., Camici, P.G., Bairey Merz, C.N., Coronary microvascular dysfunction: an update (2014) Eur Heart J, 35, pp. 1101-1111 ;
Konijnenberg, L.S.F., Damman, P., Duncker, D.J., Kloner, R.A., Nijveldt, R., van Geuns, R.J., Berry, C., van Royen, N., Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction (2019) Cardiovasc Res, , https://doi.org/10.1093/cvr/cvz301, [Epub ahead of print] ;
Hausenloy, D.J., Chilian, W., Crea, F., Davidson, S.M., Ferdinandy, P., Garcia-Dorado, D., van Royen, N., Heusch, G., The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection (2019) Cardiovasc Res, 115, pp. 1143-1155 ;
Heusch, G., The coronary circulation as a target of cardioprotection (2016) Circ Res, 118, pp. 1643-1658 ;
Manciet, L.H., Poole, D.C., McDonagh, P.F., Copeland, J.G., Mathieu-Costello, O., Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon (1994) Am J Physiol, 266, pp. H1541-H1550. , (4 Pt 2) ;
Kasseckert, S.A., Schafer, C., Kluger, A., Gligorievski, D., Tillmann, J., Schluter, K.D., Noll, T., Abdallah, Y., Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation (2009) Cardiovasc Res, 83, pp. 381-387 ;
Robbers, L.F., Eerenberg, E.S., Teunissen, P.F., Jansen, M.F., Hollander, M.R., Horrevoets, A.J., Knaapen, P., van Royen, N., Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage (2013) Eur Heart J, 34, pp. 2346-2353 ;
Betgem, R.P., de Waard, G.A., Nijveldt, R., Beek, A.M., Escaned, J., van Royen, N., Intramyocardial haemorrhage after acute myocardial infarction (2015) Nat Rev Cardiol, 12, pp. 156-167 ;
Hollander, M.R., de Waard, G.A., Konijnenberg, L.S., Meijer-van Putten, R.M., van den Brom, C.E., Paauw, N., de Vries, H.E., Van Royen, N., Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction (2016) PLoS One, 11 ;
Elsasser, A., Muller, K.D., Skwara, W., Bode, C., Kubler, W., Vogt, A.M., Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death (2002) J Am Coll Cardiol, 39, pp. 1189-1198 ;
Depre, C., Vanoverschelde, J.L., Gerber, B., Borgers, M., Melin, J.A., Dion, R., Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting (1997) J Thorac Cardiovasc Surg, 113, pp. 371-378 ;
Elsasser, A., Schlepper, M., Klovekorn, W.P., Cai, W.J., Zimmermann, R., Muller, K.D., Strasser, R., Schaper, J., Hibernating myocardium: an incomplete adaptation to ischemia (1997) Circulation, 96, pp. 2920-2931 ;
Poole-Wilson, P.A., Holmberg, S.R., Williams, A.J., A possible molecular mechanism for ‘stunning’ of the myocardium (1991) Eur Heart J, 12, pp. 25-29 ;
Bax, J.J., Visser, F.C., Poldermans, D., Elhendy, A., Cornel, J.H., Boersma, E., van Lingen, A., Visser, C.A., Time course of functional recovery of stunned and hibernating segments after surgical revascularization (2001) Circulation, 104, pp. I314-I318. , (12 ;
Schinkel, A.F., Bax, J.J., van Domburg, R., Elhendy, A., Valkema, R., Vourvouri, E.C., Sozzi, F.B., Poldermans, D., Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy (2003) J Nucl Med, 44, pp. 127-133 ;
Enriquez-Sarano, M., Akins, C.W., Vahanian, A., Mitral regurgitation (2009) Lancet, 373, pp. 1382-1394 ;
Patel, H., Mazur, W., Williams, K.A., Sr., Kalra, D.K., Myocardial viability-state of the art: is it still relevant and how to best assess it with imaging? (2018) Trends Cardiovasc Med, 28, pp. 24-37 ;
Bax, J.J., Schinkel, A.F., Boersma, E., Elhendy, A., Rizzello, V., Maat, A., Roelandt, J.R., Poldermans, D., Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis (2004) Circulation, 110, pp. II18-22. , (11 ;
La Canna, G., Rahimtoola, S.H., Visioli, O., Giubbini, R., Alfieri, O., Zognio, M., Milan, E., Ferrari, R., Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium (2000) Eur Heart J, 21, pp. 1358-1367 ;
Cwajg, J.M., Cwajg, E., Nagueh, S.F., He, Z.X., Qureshi, U., Olmos, L.I., Quinones, M.A., Zoghbi, W.A., End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography (2000) J Am Coll Cardiol, 35, pp. 1152-1161 ;
Cornel, J.H., Bax, J.J., Elhendy, A., Maat, A.P., Kimman, G.J., Geleijnse, M.L., Rambaldi, R., Fioretti, P.M., Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy (1998) J Am Coll Cardiol, 31, pp. 1002-1010 ;
Anavekar, N.S., Chareonthaitawee, P., Narula, J., Gersh, B.J., Revascularization in patients with severe left ventricular dysfunction: is the assessment of viability still viable? (2016) J Am Coll Cardiol, 67, pp. 2874-2887 ;
Schinkel, A.F., Bax, J.J., Poldermans, D., Elhendy, A., Ferrari, R., Rahimtoola, S.H., Hibernating myocardium: diagnosis and patient outcomes (2007) Curr Probl Cardiol, 32, pp. 375-410 ;
Brunken, R.C., Mody, F.V., Hawkins, R.A., Nienaber, C., Phelps, M.E., Schelbert, H.R., Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects (1992) Circulation, 86, pp. 1357-1369 ;
Chareonthaitawee, P., Gersh, B.J., Araoz, P.A., Gibbons, R.J., Revascularization in severe left ventricular dysfunction: the role of viability testing (2005) J Am Coll Cardiol, 46, pp. 567-574 ;
Knuuti, J., Schelbert, H.R., Bax, J.J., The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction (2002) Eur J Nucl Med Mol Imaging, 29, pp. 1257-1266 ;
Klein, C., Nekolla, S.G., Bengel, F.M., Momose, M., Sammer, A., Haas, F., Schnackenburg, B., Schwaiger, M., Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography (2002) Circulation, 105, pp. 162-167 ;
Thornhill, R.E., Prato, F.S., Wisenberg, G., The assessment of myocardial viability: a review of current diagnostic imaging approaches (2002) J Cardiovasc Magn Reson, 4, pp. 381-410 ;
Kim, R.J., Wu, E., Rafael, A., Chen, E.L., Parker, M.A., Simonetti, O., Klocke, F.J., Judd, R.M., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction (2000) N Engl J Med, 343, pp. 1445-1453 ;
Romero, J., Xue, X., Gonzalez, W., Garcia, M.J., CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials (2012) JACC Cardiovasc Imaging, 5, pp. 494-508 ;
Wellnhofer, E., Olariu, A., Klein, C., Grafe, M., Wahl, A., Fleck, E., Nagel, E., Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery (2004) Circulation, 109, pp. 2172-2174 ;
Neumann, F.J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A.P., Benedetto, U., Byrne, R.A., Zembala, M.O., 2018 ESC/EACTS Guidelines on myocardial revascularization (2019) Eur Heart J, 40, pp. 87-165 ;
Acampa, W., Petretta, M., Spinelli, L., Salvatore, M., Cuocolo, A., Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium (2005) Eur J Nucl Med Mol Imaging, 32, pp. 430-437 ;
Senior, R., Kaul, S., Raval, U., Lahiri, A., Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy (2002) J Nucl Cardiol, 9, pp. 454-462 ;
Meluzin, J., Cerny, J., Spinarova, L., Toman, J., Groch, L., Stetka, F., Frelich, M., Panovsky, R., Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability (2003) Eur J Heart Fail, 5, pp. 85-93 ;
Liao, L., Cabell, C.H., Jollis, J.G., Velazquez, E.J., Smith, W., Anstrom, K.J., Pappas, P.A., Landolfo, C.K., Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization (2004) Am J Cardiol, 93, pp. 1275-1279 ;
Sawada, S.G., Dasgupta, S., Nguyen, J., Lane, K.A., Gradus-Pizlo, I., Mahenthiran, J., Feigenbaum, H., Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability (2010) Am J Cardiol, 106, pp. 187-192 ;
Sicari, R., Picano, E., Cortigiani, L., Borges, A.C., Varga, A., Palagi, C., Bigi, R., Pasanisi, E., Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction (2003) Am J Cardiol, 92, pp. 1263-1266 ;
Shah, B.R., Velazquez, E., Shaw, L.K., Bart, B., O'Connor, C., Wagner, G.S., Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts (2002) Am Heart J, 143, pp. 111-117 ;
Gerber, B.L., Rousseau, M.F., Ahn, S.A., le Polain de Waroux, J.B., Pouleur, A.C., Phlips, T., Vancraeynest, D., Vanoverschelde, J.L., Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy (2012) J Am Coll Cardiol, 59, pp. 825-835 ;
Kwon, D.H., Hachamovitch, R., Popovic, Z.B., Starling, R.C., Desai, M.Y., Flamm, S.D., Lytle, B.W., Marwick, T.H., Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability (2012) Circulation, 126, pp. S3-S8. , (11 ;
Ling, L.F., Marwick, T.H., Flores, D.R., Jaber, W.A., Brunken, R.C., Cerqueira, M.D., Hachamovitch, R., Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium (2013) Circ Cardiovasc Imaging, 6, pp. 363-372 ;
Desideri, A., Cortigiani, L., Christen, A.I., Coscarelli, S., Gregori, D., Zanco, P., Komorovsky, R., Bax, J.J., The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction (2005) J Am Coll Cardiol, 46, pp. 1264-1269 ;
Tarakji, K.G., Brunken, R., McCarthy, P.M., Al-Chekakie, M.O., Abdel-Latif, A., Pothier, C.E., Blackstone, E.H., Lauer, M.S., Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction (2006) Circulation, 113, pp. 230-237 ;
Sawada, S.G., Lewis, S.J., Foltz, J., Ando, A., Khouri, S., Kaser, S., Gradus-Pizlo, I., Feigenbaum, H., Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy (2002) Am J Cardiol, 89, pp. 811-816 ;
Bounous, E.P., Mark, D.B., Pollock, B.G., Hlatky, M.A., Harrell, F.E., Jr., Lee, K.L., Rankin, J.S., Califf, R.M., Surgical survival benefits for coronary disease patients with left ventricular dysfunction (1988) Circulation, 78, pp. I151-I157. , (3 Pt 2) ;
Allman, K.C., Shaw, L.J., Hachamovitch, R., Udelson, J.E., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis (2002) J Am Coll Cardiol, 39, pp. 1151-1158 ;
Orlandini, A., Castellana, N., Pascual, A., Botto, F., Cecilia Bahit, M., Chacon, C., Luz Diaz, M., Diaz, R., Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies (2015) Int J Cardiol, 182, pp. 494-499 ;
Cleland, J.G., Calvert, M., Freemantle, N., Arrow, Y., Ball, S.G., Bonser, R.S., Chattopadhyay, S., Senior, R., The Heart Failure Revascularisation Trial (HEART) (2011) Eur J Heart Fail, 13, pp. 227-233 ;
Beanlands, R.S., Nichol, G., Huszti, E., Humen, D., Racine, N., Freeman, M., Gulenchyn, K.Y., Iwanochko, R.M., F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) (2007) J Am Coll Cardiol, 50, pp. 2002-2012 ;
Mc Ardle, B., Shukla, T., Nichol, G., deKemp, R.A., Bernick, J., Guo, A., Lim, S.P., Beanlands, R.S., Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease (2016) Circ Cardiovasc Imaging, 9 ;
Velazquez, E.J., Lee, K.L., Deja, M.A., Jain, A., Sopko, G., Marchenko, A., Ali, I.S., Rouleau, J.L., Coronary-artery bypass surgery in patients with left ventricular dysfunction (2011) N Engl J Med, 364, pp. 1607-1616 ;
Velazquez, E.J., Lee, K.L., Jones, R.H., Al-Khalidi, H.R., Hill, J.A., Panza, J.A., Michler, R.E., Rouleau, J.L., Coronary-artery bypass surgery in patients with ischemic cardiomyopathy (2016) N Engl J Med, 374, pp. 1511-1520 ;
Bonow, R.O., Maurer, G., Lee, K.L., Holly, T.A., Binkley, P.F., Desvigne-Nickens, P., Drozdz, J., Panza, J.A., Myocardial viability and survival in ischemic left ventricular dysfunction (2011) N Engl J Med, 364, pp. 1617-1625 ;
Panza, J.A., Ellis, A.M., Al-Khalidi, H.R., Holly, T.A., Berman, D.S., Oh, J.K., Pohost, G.M., Bonow, R.O., Myocardial viability and long-term outcomes in ischemic cardiomyopathy (2019) N Engl J Med, 381, pp. 739-748 ;
Packer, M., What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? (2019) Eur Heart J, , https://doi.org/10.1093/eurheartj/ehz553, [Epub ahead of print] ;
Senni, M., Adamo, M., Metra, M., Alfieri, O., Vahanian, A., Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA-FR and COAPT trials? (2019) Eur J Heart Fail, 21, pp. 852-861 ;
Packer, D.L., Prutkin, J.M., Hellkamp, A.S., Mitchell, L.B., Bernstein, R.C., Wood, F., Boehmer, J.P., Bardy, G.H., Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial (2009) Circulation, 120, pp. 2170-2176 ;
Greenberg, H., Case, R.B., Moss, A.J., Brown, M.W., Carroll, E.R., Andrews, M.L., Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II) (2004) J Am Coll Cardiol, 43, pp. 1459-1465 ;
Friedman, D.J., Al-Khatib, S.M., Zeitler, E.P., Han, J., Bardy, G.H., Poole, J.E., Bigger, J.T., Sanders, G.D., New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: a pooled analysis of 4 randomized controlled trials (2017) Am Heart J, 191, pp. 21-29 ;
Lindenfeld, J., Feldman, A.M., Saxon, L., Boehmer, J., Carson, P., Ghali, J.K., Anand, I., Bristow, M., Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure (2007) Circulation, 115, pp. 204-212 ;
Bristow, M.R., Saxon, L.A., Boehmer, J., Krueger, S., Kass, D.A., De Marco, T., Carson, P., Feldman, A.M., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure (2004) N Engl J Med, 350, pp. 2140-2150 ;
Solomon, S.D., Foster, E., Bourgoun, M., Shah, A., Viloria, E., Brown, M.W., Hall, W.J., Moss, A.J., Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy (2010) Circulation, 122, pp. 985-992 ;
Barsheshet, A., Wang, P.J., Moss, A.J., Solomon, S.D., Al-Ahmad, A., McNitt, S., Foster, E., Goldenberg, I., Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) (2011) J Am Coll Cardiol, 57, pp. 2416-2423 ;
Uretsky, B.F., Thygesen, K., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Cleland, J.G., Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial (2008) J Card Fail, 14, pp. 670-675 ;
Stone, G.W., Lindenfeld, J., Abraham, W.T., Kar, S., Lim, D.S., Mishell, J.M., Whisenant, B., Mack, M.J., Transcatheter mitral-valve repair in patients with heart failure (2018) N Engl J Med, 379, pp. 2307-2318 ;
Obadia, J.F., Messika-Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefevre, T., Mewton, N., Percutaneous repair or medical treatment for secondary mitral regurgitation (2018) N Engl J Med, 379, pp. 2297-2306 ;
Perera, D., Clayton, T., Petrie, M.C., Greenwood, J.P., O'Kane, P.D., Evans, R., Sculpher, M., Marber, M., Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy (2018) JACC Heart Fail, 6, pp. 517-526 ;
O'Meara, E., Mielniczuk, L.M., Wells, G.A., deKemp, R.A., Klein, R., Coyle, D., Mc Ardle, B., Beanlands, R., Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF project I-A: study protocol for a randomized controlled trial (2013) Trials, 14, p. 218false10078593falsefalsefalse2020-06-07T18:21:42.404+000016060trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship90989004
/api/authorship/90989004
10.16666667truefalsefalseCabac-PogoreviciI.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship90989005
/api/authorship/90989005
20.16666667falsefalsefalseAuthor10078593
/api/author/10078593
MukBalázstruetrueMukB.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship90989006
/api/authorship/90989006
30.16666667falsefalsefalseRustamovaY.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship90989007
/api/authorship/90989007
40.16666667falsefalsefalseKalogeropoulosA.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship90989008
/api/authorship/90989008
50.16666667falsefalsefalseTzeisS.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship90989009
/api/authorship/90989009
60.167falsetruetrueVardasP.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier16738995
/api/publicationidentifier/16738995
PlainSource6
/api/publicationsource/6
PublicationSourceType10001
/api/publicationsourcetype/10001
truetruetrueDOIDOIhttps://doi.org/@@@truetrue6trueIDENTICAL10.1002/ejhf.1747https://doi.org/10.1002/ejhf.1747falsetruePublicationIdentifier16738996
/api/publicationidentifier/16738996
PlainSource1
/api/publicationsource/1
PublicationSourceType10003
/api/publicationsourcetype/10003
falsetruetrueWoSWoShttps://www.webofscience.com/wos/woscc/full-record/@@@truetrue1trueIDENTICAL000510989000001https://www.webofscience.com/wos/woscc/full-record/000510989000001falsetruePublicationIdentifier16738994
/api/publicationidentifier/16738994
PlainSource3
/api/publicationsource/3
PublicationSourceType10003
/api/publicationsourcetype/10003
falsetruetrueScopusScopushttp://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@truetrue3trueIDENTICAL85078892674http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85078892674falsetruePublicationIdentifier22344109
/api/publicationidentifier/22344109
PlainSource17
/api/publicationsource/17
PublicationSourceType10003
/api/publicationsourcetype/10003
falsetruetruePubMedPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstracttruetrue17trueIDENTICAL32020756http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32020756&dopt=AbstracttruetrueSjrRating10758730
/api/sjrrating/10758730
70.1journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2705
/api/classificationexternal/2705
true2705trueD1DIRECTtruetrue
/api/publication/31233247
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Cabac-Pogorevici, I. </span> <span class="author-type"> </span> ; <span class="author-name" mtid="10078593"> <a href="/gui2/?type=authors&mode=browse&sel=10078593" target="_blank">Muk, B.</a> </span> <span class="author-type"> </span> ; <span class="author-name" > Rustamova, Y. </span> <span class="author-type"> </span> ; <span class="author-name" > Kalogeropoulos, A. </span> <span class="author-type"> </span> ; <span class="author-name" > Tzeis, S. </span> <span class="author-type"> </span> ; <span class="author-name" > Vardas, P. ✉ </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;31233247" mtid="31233247" target="_blank">Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology</a></div> <div class="pub-info"> <span class="journal-title">EUROPEAN JOURNAL OF HEART FAILURE</span> <span class="journal-volume">22</span> : <span class="journal-issue">5</span> <span class="page"> pp. 789-799. , 11 p. </span> <span class="year">(2020)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1002/ejhf.1747" target="_blank" href="https://doi.org/10.1002/ejhf.1747"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000510989000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000510989000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85078892674" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85078892674"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="32020756" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32020756&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Közlemény:31233247 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Egyeztetett </span></span> <span class="pub-core">Forrás Idéző </span> <span class="pub-type">Folyóiratcikk (Összefoglaló cikk ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Tudományos</span> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 53</span> | Független: 52 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 53 | Scopus jelölt: 28 | WoS/Scopus jelölt: 53 | DOI jelölt: 52 </div> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Cabac-Pogorevici I.
</span>
;
<span class="author-name" mtid="10078593"><a
href="/gui2/?type=authors&mode=browse&sel=10078593" target="_blank">Muk B.
(<span class="authorship-author-name">Muk Balázs</span>
<span class="authorAux-mtmt"> kardiológia, szívelégtelenség</span>)
</a>
</span>
;
<span class="author-name" >Rustamova Y.
</span>
;
<span class="author-name" >Kalogeropoulos A.
</span>
;
<span class="author-name" >Tzeis S.
</span>
;
<span class="author-name" >Vardas P. ✉
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;31233247" target="_blank">Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology</a></div> <div> <span class="journal-title">EUROPEAN JOURNAL OF HEART FAILURE</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1388-9842">1388-9842</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1879-0844">1879-0844</a>)</span>:
<span class="journal-volume">22</span> <span class="journal-issue">5</span>
<span class="page">
pp 789-799
</span> <span class="year">(2020)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Nyelv:
Angol
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1002/ejhf.1747" target="_blank" href="https://doi.org/10.1002/ejhf.1747">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000510989000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000510989000001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85078892674" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85078892674">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="32020756" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32020756&dopt=Abstract">
PubMed
</a>
</span>
</span>
<OnlyViewableByAuthor><div class="ratings">
<div class="journal-subject">Folyóirat szakterülete: Scopus - Cardiology and Cardiovascular Medicine SJR indikátor: D1</div>
</div></OnlyViewableByAuthor>
<div class="publication-citation" style="margin-left: 0.5cm;">
<span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 53</span>
| Független: 52
| Függő: 1
| Nem jelölt: 0
| WoS jelölt: 53
| Scopus jelölt: 28
| WoS/Scopus jelölt: 53
| DOI jelölt: 52
</div>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;31233247&sort=publishedYear,desc&sort=title">
Idézett közlemények száma: 6
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Közlemény: 31233247</span>
| <span class="status-data status-VALIDATED"> Egyeztetett
</span>
Forrás Idéző
| <span class="type-subtype">Folyóiratcikk
( Összefoglaló cikk
)
</span>
| <span class="pub-category">Tudományos</span>
| <span class="publication-sourceOfData">Scopus</span>
</div>
<div class="lastModified">Utolsó módosítás: 2022.12.16. 11:00 Belházyné Szombathelyi Ágnes (SZTE admin5)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Nicolae Testemitanu, State University of Medicine and Pharmacy, Chisinau, Israel
Department of Cardiology, Medical Centre Hungarian Defence Forces, Budapest, Hungary
Department of Internal Medicine 2, Azerbaijan Medical University, Baku, Azerbaijan
Cardiology Department, Mitera General Clinic - Hygeia Group, Athens, Greece ...</pre>
</div></div>